CD274 and non-small cell lung carcinoma: In the present study, we assessed TIL infiltration and PD-L1 expression of primary tumors in the NSCLC patients enrolled in the Vx-001-201 study in order to investigate whether patients with low-TIL or PD-L1(-) tumors might be more responsive to the Vx-001 vaccine.